Christopher Simon
2018
In 2018, Christopher Simon earned a total compensation of $7.9M as President and Chief Executive Officer at Haemonetics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,399,830 |
|---|---|
| Option Awards | $1,062,497 |
| Salary | $858,462 |
| Stock Awards | $4,396,692 |
| Other | $133,829 |
| Total | $7,851,310 |
Simon received $4.4M in stock awards, accounting for 56% of the total pay in 2018.
Simon also received $1.4M in non-equity incentive plan, $1.1M in option awards, $858.5K in salary and $133.8K in other compensation.
Rankings
In 2018, Christopher Simon's compensation ranked 1,048th out of 14,244 executives tracked by ExecPay. In other words, Simon earned more than 92.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,048 out of 14,244 | 93rd |
Division Manufacturing | 349 out of 5,765 | 94th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 45 out of 849 | 95th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 20 out of 547 | 96th |
Industry Surgical and Medical Instruments and Apparatus | 12 out of 348 | 97th |
Source: SEC filing on June 12, 2019.
Simon's colleagues
We found three more compensation records of executives who worked with Christopher Simon at Haemonetics in 2018.
News
Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
June 17, 2022
Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
June 17, 2021
Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
June 8, 2020
Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
June 12, 2019